Vanguard Capital Management »

Corcept Therapeutics Incorporated shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $164M 4.1M 40.31

More positions owned by Vanguard Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Capital Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Ingalls & Snyder
Renaissance Technologies
Vanguard Portfolio Management
Vanguard Capital Management
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
First Trust Advisors
Dimensional Fund Advisors
Tang Capital Management
Caption Management
UBS Group
Jane Street

View all funds holding Corcept Therapeutics Incorporated